|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| C07K 16/32 | (2006.01) |
| (11) | Number of the document | 1189641 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00943115.6 |
| Date of filing the European patent application | 2000-06-23 | |
| (97) | Date of publication of the European application | 2002-03-27 |
| (45) | Date of publication and mention of the grant of the patent | 2009-07-29 |
| (46) | Date of publication of the claims translation | 2009-11-25 |
| (86) | Number | PCT/US2000/017366 |
| Date | 2000-06-23 |
| (87) | Number | WO 2001/000245 |
| Date | 2001-01-04 |
| (30) | Number | Date | Country code |
| 141316 P | 1999-06-25 | US |
| (72) |
ADAMS, Camellia, W., US
PRESTA, Leonard, G., US
SLIWKOWSKY, Mark, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco CA 94080-4990,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Humanizuoti anti-ErbB2 antikūnai ir gydymas anti-ErbB2 antikūnais |
| HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2019-06-17 | 20 | 347.00 EUR |